2022
DOI: 10.1155/2022/4291758
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic Disorders and COVID-19: From Pathophysiology to Treatment Strategy

Abstract: Following the SARS-CoV-2 outbreak and the subsequent development of the COVID-19 pandemic, organs such as the lungs, kidneys, liver, heart, and brain have been identified as priority organs. Liver diseases are considered a risk factor for high mortality from the COVID-19 pandemic. Besides, liver damage has been demonstrated in a substantial proportion of patients with COVID-19, especially those with severe clinical symptoms. Furthermore, antiviral medications, immunosuppressive drugs after liver transplantatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(12 citation statements)
references
References 112 publications
0
12
0
Order By: Relevance
“…Less frequently, we can find higher values of total and direct bilirubin and reduced values of synthetic liver capability (e.g., reduced total albumin values and higher prothrombin time). These findings do not differ between men and women with COVID-19 [ 11 ].…”
Section: Resultsmentioning
confidence: 96%
See 4 more Smart Citations
“…Less frequently, we can find higher values of total and direct bilirubin and reduced values of synthetic liver capability (e.g., reduced total albumin values and higher prothrombin time). These findings do not differ between men and women with COVID-19 [ 11 ].…”
Section: Resultsmentioning
confidence: 96%
“…However, increased AST and ALP levels are significantly and specifically associated with COVID-19 liver injury vs. derangement of ALT and total bilirubin values [ 9 , 10 , 11 ].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations